
Pharmaceuticals · Listed on BSE , NSE · 27 Nov 2026 - 01 Dec 2026
Jagat JoshiLot size details will be updated soon.
Founded in 2008, Integris Medtech is one of the leading global medical products and laboratory solutions providers in India. The company develops, manufactures, commercialises, and sells a diverse range of medical devices and solutions, including cardiovascular devices, clinical diagnostics, and scientific laboratory solutions. The firm operates its manufacturing facilities across India, Germany, and the Netherlands, and supplies its products to more than 65 international markets across India, Europe, and Southeast Asia.
Integris Medtech has two major business segments: Cardiovascular Devices and Laboratory Solutions. Furthermore, the company supplies its products to more than 9500 labs, over 2,000 hospitals and Cath labs, and offers more than 22,000 different products. Furthermore, the firm provides its products and services to laboratories and hospitals across five countries: India, Singapore, Thailand, Malaysia, and the Philippines.
| Date & Time | GMP (₹) | Est. Listing Price | Est. Gain (%) | Est. Profit / Lot (₹) |
|---|---|---|---|---|
| 20-Nov-2026 06:19 PM | +₹0 | — | — | ₹0 |
Subscription status will be updated soon.
| Period Ended | 30 JUN 2025 | 31 MAR 2025 | 31 MAR 2024 | 31 MAR 2023 |
|---|---|---|---|---|
| Assets | 4019.62 | 3641.34 | 2989.20 | 2553.87 |
| Total Income | 508.93 | 1959.58 | 1582.26 | 1369.66 |
| Profit After Tax | 267.57 | 70.68 | -4.88 | -40.54 |
| EBITDA | 78.73 | 309.40 | 190.45 | 168.82 |
| NET Worth | 3889.99 | 2752.52 | 2681.02 | 2629.52 |
| Reserves and Surplus | 2299.84 | 1150.74 | 1135.71 | 1073.12 |
| Total Borrowing | 793.42 | 1729.46 | 813.10 | 556.54 |
| Company Name | EPS (₹) | P/E (x) | NAV (₹) | RoNW (%) | Income (₹ Cr) |
|---|---|---|---|---|---|
| Laxmi Dental Limited | 6.07 | 53.95 | 37.71 | 16.09 | 239.11 |
| Poly Medicure Limited | 34.13 | 56.02 | 278.46 | 12.26 | 1,669.83 |
Evercure Holdings Pte.Ltd., Medicore Holdings Pte.Ltd., Gurmit Singh Chugh, Punita Sharma are the company's promoters of Integris Medtech.
| Particular | Pre IPO | Post IPO |
|---|---|---|
| Promoter and Promoter Group | 83.24% | 0.00% |
| Others* | 16.76% | 0.00% |
Join the discussion
Please sign in to leave a comment or reply.